 |
||||
|
||||
|
||||
|
||||
Previous Article | Next Article
The Journal of Neuroscience, March 15, 1998, 18(6):1979-1986
Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter
Sara R. Jones1, Raul R. Gainetdinov1, R. Mark Wightman2, and Marc G. Caron1 1 Howard Hughes Medical Institute Laboratories, Departments of Cell Biology and Medicine, Duke University Medical Center, Durham, North Carolina 27710, and 2 Department of Chemistry and Curriculum in Neurobiology, University of North Carolina, Chapel Hill, North Carolina 27599
Amphetamine (AMPH) inhibits uptake and causes release of dopamine (DA) from presynaptic terminals. AMPH can act on both vesicular storage of DA and directly on the dopamine transporter (DAT). To assess the relative importance of these two processes, we have examined the releasing actions of AMPH in mice with a genetic deletion of the DAT. The sequence of actions of AMPH has been determined by following the real time changes of DA in the extracellular fluid of intact tissue with fast scan cyclic voltammetry. In striatal slices from wild-type mice, AMPH causes a gradual (~30 min) increase in extracellular DA, with a concomitant disappearance of the pool of DA available for depolarization-evoked release. Conversely, in slices from mice lacking the DAT, although a similar disappearance of electrically stimulated DA release occurs, extracellular DA does not increase. Similarly, microdialysis measurements of DA after AMPH in freely moving animals show no change in mice lacking the DAT, whereas it increases 10-fold in wild-type mice. In contrast, redistribution of DA from vesicles to the cytoplasm by the use of a reserpine-like compound, Ro4-1284, does not increase extracellular DA in slices from wild-type animals; however, subsequent addition of AMPH induces rapid (<5 min) release of DA. Thus, the DAT is required for the releasing action, but not the vesicle-depleting action, of AMPH on DA neurons, and the latter represents the rate-limiting step in the effects of AMPH. Furthermore, these findings suggest that in the absence of pharmacological manipulation, such as the use of amphetamine, endogenous cytoplasmic DA normally does not reach sufficient concentrations to reverse the DAT.
Key words: amphetamine; dopamine transporter; knockout; mice; voltammetry; Ro4-1284; tetrabenazine; synaptic vesicles; microdialysis; dopamine
Copyright © 1998 Society for Neuroscience 0270-6474/98/1861979-08$05.00/0
This article has been cited by other articles:
A. Vinuela, P. J. Hallett, C. Reske-Nielsen, M. Patterson, T. D. Sotnikova, M. G. Caron, R. R. Gainetdinov, and O. Isacson
Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease
Brain, November 6, 2008; (2008) awn192v1.
[Abstract] [Full Text] [PDF]
L. S. Barak, A. Salahpour, X. Zhang, B. Masri, T. D. Sotnikova, A. J. Ramsey, J. D. Violin, R. J. Lefkowitz, M. G. Caron, and R. R. Gainetdinov
Pharmacological Characterization of Membrane-Expressed Human Trace Amine-Associated Receptor 1 (TAAR1) by a Bioluminescence Resonance Energy Transfer cAMP Biosensor
Mol. Pharmacol., September 1, 2008; 74(3): 585 - 594.
[Abstract] [Full Text] [PDF]
O. D. HOWES, A. J. MONTGOMERY, M. ASSELIN, R. M. MURRAY, P. M. GRASBY, and P. K. McGUIRE
Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis
The British Journal of Psychiatry, December 1, 2007; 191(51): s13 - s18.
[Abstract] [Full Text] [PDF]
N. Wu, C. Cepeda, X. Zhuang, and M. S. Levine
Altered Corticostriatal Neurotransmission and Modulation in Dopamine Transporter Knock-Down Mice
J Neurophysiol, July 1, 2007; 98(1): 423 - 432.
[Abstract] [Full Text] [PDF]
References
PsychiatryOnline CME, May 1, 2007; 2007(1): 2 - 2.
[Full Text]
N. D. Volkow, G.-J. Wang, J. S. Fowler, F. Telang, M. Jayne, and C. Wong
Stimulant-Induced Enhanced Sexual Desire as a Potential Contributing Factor in HIV Transmission
Am J Psychiatry, January 1, 2007; 164(1): 157 - 160.
[Abstract] [Full Text] [PDF]
K. Dzirasa, S. Ribeiro, R. Costa, L. M. Santos, S.-C. Lin, A. Grosmark, T. D. Sotnikova, R. R. Gainetdinov, M. G. Caron, and M. A. L. Nicolelis
Dopaminergic Control of Sleep-Wake States
J. Neurosci., October 11, 2006; 26(41): 10577 - 10589.
[Abstract] [Full Text] [PDF]
T. D. Sotnikova, M. G. Caron, and R. R. Gainetdinov
DDD mice, a novel acute mouse model of Parkinson's disease.
Neurology, October 10, 2006; 67(7 Suppl 2): S12 - S17.
[Abstract] [Full Text]
J. S. Partilla, A. G. Dempsey, A. S. Nagpal, B. E. Blough, M. H. Baumann, and R. B. Rothman
Interaction of Amphetamines and Related Compounds at the Vesicular Monoamine Transporter
J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 237 - 246.
[Abstract] [Full Text] [PDF]
N. D. VOLKOW
Stimulant Medications: How to Minimize Their Reinforcing Effects?
Am J Psychiatry, March 1, 2006; 163(3): 359 - 361.
[Full Text] [PDF]
J. F. Cheer, M. L. A. V. Heien, P. A. Garris, R. M. Carelli, and R. M. Wightman
Simultaneous dopamine and single-unit recordings reveal accumbens GABAergic responses: Implications for intracranial self-stimulation
PNAS, December 27, 2005; 102(52): 19150 - 19155.
[Abstract] [Full Text] [PDF]
R. D. Blakely, L. J. DeFelice, and A. Galli
Biogenic Amine Neurotransmitter Transporters: Just When You Thought You Knew Them
Physiology, August 1, 2005; 20(4): 225 - 231.
[Abstract] [Full Text] [PDF]
D. G. Smith, E. T. Tzavara, J. Shaw, S. Luecke, M. Wade, R. Davis, C. Salhoff, G. G. Nomikos, and D. R. Gehlert
Mesolimbic Dopamine Super-Sensitivity in Melanin-Concentrating Hormone-1 Receptor-Deficient Mice
J. Neurosci., January 26, 2005; 25(4): 914 - 922.
[Abstract] [Full Text] [PDF]
A.-K. Meinild, H. H. Sitte, and U. Gether
Zinc Potentiates an Uncoupled Anion Conductance Associated with the Dopamine Transporter
J. Biol. Chem., November 26, 2004; 279(48): 49671 - 49679.
[Abstract] [Full Text] [PDF]
N. S. Bamford, S. Robinson, R. D. Palmiter, J. A. Joyce, C. Moore, and C. K. Meshul
Dopamine Modulates Release from Corticostriatal Terminals
J. Neurosci., October 27, 2004; 24(43): 9541 - 9552.
[Abstract] [Full Text] [PDF]
C. J. Wilhelm, R. A. Johnson, P. G. Lysko, A. J. Eshleman, and A. Janowsky
Effects of Methamphetamine and Lobeline on Vesicular Monoamine and Dopamine Transporter-Mediated Dopamine Release in a Cotransfected Model System
J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1142 - 1151.
[Abstract] [Full Text] [PDF]
J. C. Bemis and R. F. Seegal
PCB-Induced Inhibition of the Vesicular Monoamine Transporter Predicts Reductions in Synaptosomal Dopamine Content
Toxicol. Sci., August 1, 2004; 80(2): 288 - 295.
[Abstract] [Full Text] [PDF]
E. A. Budygin, M. S. Brodie, T. D. Sotnikova, Y. Mateo, C. E. John, M. Cyr, R. R. Gainetdinov, and S. R. Jones
Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine
PNAS, May 18, 2004; 101(20): 7781 - 7786.
[Abstract] [Full Text] [PDF]
K. M. Kahlig, J. A. Javitch, and A. Galli
Amphetamine Regulation of Dopamine Transport: COMBINED MEASUREMENTS OF TRANSPORTER CURRENTS AND TRANSPORTER IMAGING SUPPORT THE ENDOCYTOSIS OF AN ACTIVE CARRIER
J. Biol. Chem., March 5, 2004; 279(10): 8966 - 8975.
[Abstract] [Full Text] [PDF]
Y. Mateo, E. A. Budygin, C. E. John, and S. R. Jones
Role of serotonin in cocaine effects in mice with reduced dopamine transporter function
PNAS, January 6, 2004; 101(1): 372 - 377.
[Abstract] [Full Text] [PDF]
N. D. Volkow and J. M. Swanson
Variables That Affect the Clinical Use and Abuse of Methylphenidate in the Treatment of ADHD
Am J Psychiatry, November 1, 2003; 160(11): 1909 - 1918.
[Abstract] [Full Text] [PDF]
D. C. Cooper, S. J. Moore, N. P. Staff, and N. Spruston
Psychostimulant-Induced Plasticity of Intrinsic Neuronal Excitability in Ventral Subiculum
J. Neurosci., October 29, 2003; 23(30): 9937 - 9946.
[Abstract] [Full Text] [PDF]
J. L. CADET, S. JAYANTHI, and X. DENG
Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis
FASEB J, October 1, 2003; 17(13): 1775 - 1788.
[Abstract] [Full Text] [PDF]
F. Fornai, P. Lenzi, M. Gesi, M. Ferrucci, G. Lazzeri, C. L. Busceti, R. Ruffoli, P. Soldani, S. Ruggieri, M. G. Alessandri, et al.
Fine Structure and Biochemical Mechanisms Underlying Nigrostriatal Inclusions and Cell Death after Proteasome Inhibition
J. Neurosci., October 1, 2003; 23(26): 8955 - 8966.
[Abstract] [Full Text] [PDF]
E. V. Mosharov, L.-W. Gong, B. Khanna, D. Sulzer, and M. Lindau
Intracellular Patch Electrochemistry: Regulation of Cytosolic Catecholamines in Chromaffin Cells
J. Neurosci., July 2, 2003; 23(13): 5835 - 5845.
[Abstract] [Full Text] [PDF]
M. K. Loder and H. E. Melikian
The Dopamine Transporter Constitutively Internalizes and Recycles in a Protein Kinase C-regulated Manner in Stably Transfected PC12 Cell Lines
J. Biol. Chem., June 6, 2003; 278(24): 22168 - 22174.
[Abstract] [Full Text] [PDF]
A. Androutsellis-Theotokis, N. R. Goldberg, K. Ueda, T. Beppu, M. L. Beckman, S. Das, J. A. Javitch, and G. Rudnick
Characterization of a Functional Bacterial Homologue of Sodium-dependent Neurotransmitter Transporters
J. Biol. Chem., April 4, 2003; 278(15): 12703 - 12709.
[Abstract] [Full Text] [PDF]
H. Khoshbouei, H. Wang, J. D. Lechleiter, J. A. Javitch, and A. Galli
Amphetamine-induced Dopamine Efflux. A VOLTAGE-SENSITIVE AND INTRACELLULAR Na+-DEPENDENT MECHANISM
J. Biol. Chem., March 28, 2003; 278(14): 12070 - 12077.
[Abstract] [Full Text] [PDF]
C. A. Paladini, S. Robinson, H. Morikawa, J. T. Williams, and R. D. Palmiter
Dopamine controls the firing pattern of dopamine neurons via a network feedback mechanism
PNAS, March 4, 2003; 100(5): 2866 - 2871.
[Abstract] [Full Text] [PDF]
K. E. Larsen, E. A. Fon, T. G. Hastings, R. H. Edwards, and D. Sulzer
Methamphetamine-Induced Degeneration of Dopaminergic Neurons Involves Autophagy and Upregulation of Dopamine Synthesis
J. Neurosci., October 15, 2002; 22(20): 8951 - 8960.
[Abstract] [Full Text] [PDF]
J. Lotharius, S. Barg, P. Wiekop, C. Lundberg, H. K. Raymon, and P. Brundin
Effect of Mutant alpha -Synuclein on Dopamine Homeostasis in a New Human Mesencephalic Cell Line
J. Biol. Chem., October 4, 2002; 277(41): 38884 - 38894.
[Abstract] [Full Text] [PDF]
J. Lotharius and P. Brundin
Impaired dopamine storage resulting from {alpha}-synuclein mutations may contribute to the pathogenesis of Parkinson's disease
Hum. Mol. Genet., October 1, 2002; 11(20): 2395 - 2407.
[Abstract] [Full Text] [PDF]
I. N. KRASNOVA, M. T. MCCOY, B. LADENHEIM, and J. L. CADET
cDNA array analysis of gene expression profiles in the striata of wild-type and Cu/Zn superoxide dismutase transgenic mice treated with neurotoxic doses of amphetamine
FASEB J, September 1, 2002; 16(11): 1379 - 1388.
[Abstract] [Full Text] [PDF]
J. A. Moron, A. Brockington, R. A. Wise, B. A. Rocha, and B. T. Hope
Dopamine Uptake through the Norepinephrine Transporter in Brain Regions with Low Levels of the Dopamine Transporter: Evidence from Knock-Out Mouse Lines
J. Neurosci., January 15, 2002; 22(2): 389 - 395.
[Abstract] [Full Text] [PDF]
D. J. Gerber, T. D. Sotnikova, R. R. Gainetdinov, S. Y. Huang, M. G. Caron, and S. Tonegawa
Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice
PNAS, December 18, 2001; 98(26): 15312 - 15317.
[Abstract] [Full Text] [PDF]
Y. Schmitz, C. J. Lee, C. Schmauss, F. Gonon, and D. Sulzer
Amphetamine Distorts Stimulation-Dependent Dopamine Overflow: Effects on D2 Autoreceptors, Transporters, and Synaptic Vesicle Stores
J. Neurosci., August 15, 2001; 21(16): 5916 - 5924.
[Abstract] [Full Text] [PDF]
Y. U. Adachi, K. Watanabe, T. Satoh, and E. S. Vizi
Halothane potentiates the effect of methamphetamine and nomifensine on extracellular dopamine levels in rat striatum: a microdialysis study
Br. J. Anaesth., June 1, 2001; 86(6): 837 - 845.
[Abstract] [Full Text] [PDF]
L. Kantor, G. H. K. Hewlett, Y. H. Park, S. M. Richardson-Burns, M. J. Mellon, and M. E. Gnegy
Protein Kinase C and Intracellular Calcium Are Required for Amphetamine-Mediated Dopamine Release via the Norepinephrine Transporter in Undifferentiated PC12 Cells
J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1016 - 1024.
[Abstract] [Full Text]
R. R. Metzger, H. M. Haughey, D. G. Wilkins, J. W. Gibb, G. R. Hanson, and A. E. Fleckenstein
Methamphetamine-Induced Rapid Decrease in Dopamine Transporter Function: Role of Dopamine and Hyperthermia
J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 1077 - 1085.
[Abstract] [Full Text]
S. J. Cragg, C. J. Hille, and S. A. Greenfield
Dopamine Release and Uptake Dynamics within Nonhuman Primate Striatum In Vitro
J. Neurosci., November 1, 2000; 20(21): 8209 - 8217.
[Abstract] [Full Text] [PDF]
G Giovannoni, J D O'Sullivan, K Turner, A J Manson, and A J L Lees
Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies
J. Neurol. Neurosurg. Psychiatry, April 1, 2000; 68(4): 423 - 428.
[Abstract] [Full Text] [PDF]
P. Brown and M. E. Molliver
Dual Serotonin (5-HT) Projections to the Nucleus Accumbens Core and Shell: Relation of the 5-HT Transporter to Amphetamine-Induced Neurotoxicity
J. Neurosci., March 1, 2000; 20(5): 1952 - 1963.
[Abstract] [Full Text] [PDF]
ADHD: Unanswered Questions and Controversies
Journal Watch Psychiatry, November 1, 1999; 1999(1101): 17 - 17.
[Full Text]
M. S. Szczypka, M. A. Rainey, D. S. Kim, W. A. Alaynick, B. T. Marck, A. M. Matsumoto, and R. D. Palmiter
Feeding behavior in dopamine-deficient mice
PNAS, October 12, 1999; 96(21): 12138 - 12143.
[Abstract] [Full Text] [PDF]
S. Ramamoorthy and R. D. Blakely
Phosphorylation and Sequestration of Serotonin Transporters Differentially Modulated by Psychostimulants
Science, July 30, 1999; 285(5428): 763 - 766.
[Abstract] [Full Text]
L. Kantor, G. H. K. Hewlett, and M. E. Gnegy
Enhanced Amphetamine- and K+-Mediated Dopamine Release in Rat Striatum after Repeated Amphetamine: Differential Requirements for Ca2+- and Calmodulin-Dependent Phosphorylation and Synaptic Vesicles
J. Neurosci., May 15, 1999; 19(10): 3801 - 3808.
[Abstract] [Full Text] [PDF]
A. J. Eshleman, M. Carmolli, M. Cumbay, C. R. Martens, K. A. Neve, and A. Janowsky
Characteristics of Drug Interactions with Recombinant Biogenic Amine Transporters Expressed in the Same Cell Type
J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 877 - 885.
[Abstract] [Full Text]
F. Fumagalli, R. R. Gainetdinov, Y.-M. Wang, K. J. Valenzano, G. W. Miller, and M. G. Caron
Increased Methamphetamine Neurotoxicity in Heterozygous Vesicular Monoamine Transporter 2 Knock-Out Mice
J. Neurosci., April 1, 1999; 19(7): 2424 - 2431.
[Abstract] [Full Text] [PDF]
R. R. Gainetdinov, W. C. Wetsel, S. R. Jones, E. D. Levin, M. Jaber, and M. G. Caron
Role of Serotonin in the Paradoxical Calming Effect of Psychostimulants on Hyperactivity
Science, January 15, 1999; 283(5400): 397 - 401.
[Abstract] [Full Text]
A. Galli, R. D. Blakely, and L. J. DeFelice
Patch-clamp and amperometric recordings from norepinephrine transporters: Channel activity and voltage-dependent uptake
PNAS, October 27, 1998; 95(22): 13260 - 13265.
[Abstract] [Full Text] [PDF]
F. Fumagalli, R. R. Gainetdinov, K. J. Valenzano, and M. G. Caron
Role of Dopamine Transporter in Methamphetamine-Induced Neurotoxicity: Evidence from Mice Lacking the Transporter
J. Neurosci., July 1, 1998; 18(13): 4861 - 4869.
[Abstract] [Full Text] [PDF]
J. Lotharius and K. L. O'Malley
The Parkinsonism-inducing Drug 1-Methyl-4-phenylpyridinium Triggers Intracellular Dopamine Oxidation. A NOVEL MECHANISM OF TOXICITY
J. Biol. Chem., December 1, 2000; 275(49): 38581 - 38588.
[Abstract] [Full Text] [PDF]
C. Saunders, J. V. Ferrer, L. Shi, J. Chen, G. Merrill, M. E. Lamb, L. M. F. Leeb-Lundberg, L. Carvelli, J. A. Javitch, and A. Galli
Amphetamine-induced loss of human dopamine transporter activity: An internalization-dependent and cocaine-sensitive mechanism
PNAS, June 6, 2000; 97(12): 6850 - 6855.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|